BMJ Open Gastroenterology (Nov 2024)

Qualitative service evaluation of a multimodal pilot service for early detection of liver disease in high-risk groups: ‘Alright My Liver?’

  • Lucy Yardley,
  • Kushala Abeysekera,
  • Matthew Hickman,
  • Fiona H Gordon,
  • Hannah Bowers,
  • Tom May,
  • Sally Tilden,
  • Ann Jane Archer,
  • Joanna Kesten

DOI
https://doi.org/10.1136/bmjgast-2024-001560
Journal volume & issue
Vol. 11, no. 1

Abstract

Read online

Objective Liver disease is a growing cause of premature death in the UK. The National Health Service in England (NHS England) has funded regional early detection programmes through Community Liver Health Check pilots. ‘Alright My Liver?’ is Bristol and Severn’s pilot service offering early detection of liver disease through screening events serving populations at risk, including people with a history of drug or alcohol use, type 2 diabetes and obesity. The service offers point-of-care testing for liver disease and a supported follow-up process.Methods Semistructured interviews were conducted with 14 service users and six service providers over a 6-month period using diversity sampling. Topic guides encouraged discussion of experiences of the service as well as barriers and facilitators to accessing the service. Data were analysed using thematic analysis, and positive and negative comments pertaining to the service were collated in a ‘table of changes’ to inform optimisation.Results Three main themes were identified: (1) motivations for engagement, (2) experience of the service and (3) health impacts. Key motivations for engagement were screening as a novel opportunity, a response to immediate health concerns or as reassurance. Service users commented on its convenience and that staff interactions were warm and informative. Some felt that follow-up could be more intensive. Impacts varied depending on perceived risk factors and screening results but generally involved stating a commitment to healthy lifestyle changes, including reducing alcohol use.Conclusion Targeted screening for liver disease in high-risk groups through this pilot service was deemed an appropriate and accessible intervention, with important optimisations identified.